Fig. 3 | Scientific Reports

Fig. 3

From: Atorvastatin negatively regulates MAPK pathway in vitro to inhibit proliferation, migration, and invasion of hepatocellular carcinoma cells

Fig. 3

Effect of ATO on tumor growth in hepatocellular carcinoma xenograft animal model. (A), Tumor tissues of mice in different concentrations of ATO treatment groups. (B) Tumor volume change curves. (C) Body weight curves of mice. groups A and B are normal diet, groups C and D are high-fat diet, and groups B and D are ATO-treated groups. (D–G) Tumor GO, KEGG and KGO analysis of ATO-treated mice in the normal diet group. (H–K) Tumor GO, KEGG and KGO analysis of ATO-treated mice in the high-fat diet group.groups a and b were normal diet, groups c and d were high-fat diet, and b and d were ATO-treated groups.*P < 0.05,**P < 0.01,***P < 0.001.

Back to article page